• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Smart for Life Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8/26/24 4:55:52 PM ET
    $SMFL
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SMFL alert in real time by email
    false 0001851860 0001851860 2024-08-20 2024-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

    CURRENT REPORT

     

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 26, 2024 (August 20, 2024)

     

    SMART FOR LIFE, INC.
    (Exact name of registrant as specified in its charter)

     

    Nevada   001-41290   81-5360128
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    990 S Rogers Circle, Suite 3, Boca Raton, FL   33487
    (Address of principal executive offices)   (Zip Code)

     

      (786) 749-1221  
      (Registrant’s telephone number, including area code)  

     

     
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.0001 per share   SMFL   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

    Emerging Growth Company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    As previously disclosed, on December 5, 2023, Smart for Life, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the Nasdaq stockholders’ equity requirement of $2,500,000 or the alternative criteria for continued listing on The Nasdaq Capital Market as set forth in Listing Rule 5550(b)(1) (the “Equity Rule”), given that the Company’s Form 10-Q for the period ended September 30, 2023 evidenced stockholders’ equity of $951,836, and that the staff of Nasdaq had determined to delist the Company’s securities from Nasdaq unless the Company requested an appeal of the determination. Based on the foregoing, the Company timely requested a hearing before a Nasdaq hearings panel. The hearing request stayed the delisting pending the conclusion of the hearings process.

     

    As previously disclosed, on January 5, 2024, the Company received an additional notification letter from Nasdaq notifying the Company that it is not in compliance with the requirement to hold an annual meeting of shareholders since the Company did not hold an annual meeting in 2023. The letter stated that the hearings panel will consider this matter in rendering a determination regarding the Company’s continued listing on Nasdaq.

     

    As previously disclosed, on April 17, 2024, the Company received an additional notification letter from Nasdaq indicating that the Company is now delinquent in filing its Form 10-K for the year ended December 31, 2023, which serves as an additional basis for the delisting of the Company’s securities from The Nasdaq Capital Market. The letter stated that the hearings panel will consider this matter in rendering a determination regarding the Company’s continued listing on Nasdaq. In that regard, the letter stated that the Company should present its views with respect to this additional deficiency to the hearings panel no later than April 24, 2024.

     

    As previously disclosed, on April 24, 2024, the Company received an additional notification letter from Nasdaq notifying the Company that its securities had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Bid Rule”). The notification letter further stated that while a company would normally be afforded a 180-calendar day period to demonstrate compliance with the Bid Rule, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period specified in Rule 5810(c)(3)(A) due to the fact that the Company effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one. Accordingly, the letter stated that the hearings panel will consider this matter in rendering a determination regarding the Company’s continued listing on Nasdaq and requested that the Company present its views with respect to this additional deficiency to the hearings panel by May 1, 2024.

     

    As previously disclosed, on May 21, 2024, the Company received an additional notification letter from Nasdaq indicating that the Company is now delinquent in filing its Form 10-Q for the period ended March 31, 2024, which serves as an additional basis for the delisting of the Company’s securities from The Nasdaq Capital Market. The letter stated that the hearings panel will consider this matter in rendering a determination regarding the Company’s continued listing on Nasdaq. In that regard, the letter stated that the Company should present its views with respect to this additional deficiency to the hearings panel no later than May 28, 2024.

     

    On August 20, 2024, the Company received an additional notification letter from Nasdaq indicating that the Company is now delinquent in filing its Form 10-Q for the period ended June 30, 2024, which serves as an additional basis for the delisting of the Company’s securities from The Nasdaq Capital Market. The letter stated that the hearings panel will consider this matter in rendering a determination regarding the Company’s continued listing on Nasdaq. In that regard, the letter stated that the Company should present its views with respect to this additional deficiency to the hearings panel no later than August 27, 2024.

     

    At the hearing, which was held on March 12, 2024, the Company presented its plan for regaining compliance with the Equity Rule and presented its views with respect to the additional deficiency relating to the annual meeting, and requested a further extension so that it may complete the execution of its plan. Although the Company believes its plan will be sufficient to enable it to regain compliance, no assurance can be provided that Nasdaq will ultimately accept the Company’s plan or that the Company will ultimately regain compliance with the Equity Rule or the Bid Rule.

     

    Notably, the Company filed a Form 8-K on March 7, 2024 disclosing that, as a result of its restructuring plan, including recapitalization with equity and debt financings, the sale of certain non-performing assets and the liquidation of its senior debt facility, the Company had stockholder’s equity of over $2.5 million. In addition, through further improvements to the balance sheet, the Company has an estimated stockholders’ equity of $6 million as of the date hereof.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 26, 2024

    SMART FOR LIFE, INC.
       
      /s/ Darren C. Minton
      Name:  Darren C. Minton
      Title: Chief Executive Officer

     

     

    2

     

     

     

    Get the next $SMFL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SMFL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SMFL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Smart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders' Equity Following Successful Restructuring Efforts

      MIAMI, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC:SMFL) ("Smart for Life" or the "Company"), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced significant progress in strengthening its balance sheet following a series of restructuring initiatives over the past several quarters. The Company has significantly improved its financial position, transitioning from negative net stockholders' equity to over $9.4 million in positive net stockholders' equity as of September 20, 2024. The Company also announced that it has successfully filed its 2023 annual report on Form 10-K

      9/23/24 5:54:48 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full Compliance

      MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC:SMFL) ("Smart for Life" or the "Company"), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today provided an update following its delisting from Nasdaq, which was primarily due to delays in the completion of its audit. The Company's common stock continues to be quoted on the OTC Markets, and the ticker symbol "SMFL" remains unchanged. Management believes this move to the OTC Markets is temporary and the Company plans to reapply for listing as soon as it is fully compliant with the listing requirements. "We are working diligently

      9/20/24 4:40:41 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart For Life Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

      MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced that Darren Minton, Chief Executive Officer of Smart For Life, will be participating at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th - 11th, 2024 at the Lotte New York Palace Hotel in New York City. The H.C. Wainwright Global Investment Conference brings together companies, industry professionals and investors from various business sectors, including Heath & Wellness, for

      9/9/24 8:00:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Hrt Financial Lp sold $33,620 worth of Class A Shares (39,093 units at $0.86), decreasing direct ownership by 86% to 6,543 units (SEC Form 4)

      4 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/12/24 11:55:41 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Large owner Hrt Financial Lp sold $30,996 worth of Class A Shares (29,802 units at $1.04) and bought $37,985 worth of Class A Shares (41,684 units at $0.91), increasing direct ownership by 35% to 45,636 units (SEC Form 4)

      4 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/11/24 2:48:13 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • New insider Hrt Financial Lp claimed ownership of 33,754 units of Class A Shares (SEC Form 3)

      3 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/11/24 2:34:56 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Financials

    Live finance-specific insights

    See more
    • Smart for Life Announces Q2 2022 Financial Results

      Revenue Increases 401.2% Year-Over-Year to $4.3 Million for the Second Quarter of 2022 Due to Successful Acquisition Strategy Gross Profit Margin Increases to 41.6% Versus 1.1% for the Same Period Last Year MIAMI, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today provided a business update and reported financial results for the second quarter ended June 30, 2022. "We continue to generate solid year-over-year growth with revenues increasing more than four-fold to $4.3 million for the second quar

      8/15/22 4:30:00 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • REMINDER: Smart for Life to Host a Conference Call Today to Discuss Ceautamed Worldwide Acquisition, Positive Developments, and New Strategic Initiatives

      MIAMI, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, reminds investors that it will host a conference call today, Wednesday, August 10, 2022, at 4:15 P.M. Eastern Time (ET) to discuss the Ceautamed Worldwide acquisition, positive developments, and new strategic initiatives. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 354190. A webcast of the call may be accessed at htt

      8/10/22 9:15:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life to Host a Conference Call to Discuss Ceautamed Worldwide Acquisition, Positive Developments, and New Strategic Initiatives

      MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today announced it will host a conference call on Wednesday, August 10, 2022, at 4:15 P.M. Eastern Time (ET) to discuss the Ceautamed Worldwide acquisition, positive developments, and new strategic initiatives. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 354190. A webcast of the call may be accessed at https://www.we

      8/8/22 9:15:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Smart for Life Inc.

      25-NSE - SMART FOR LIFE, INC. (0001851860) (Subject)

      3/21/25 11:31:13 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - SMART FOR LIFE, INC. (0001851860) (Filer)

      12/13/24 5:00:10 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form NT 10-Q filed by Smart for Life Inc.

      NT 10-Q - SMART FOR LIFE, INC. (0001851860) (Filer)

      11/14/24 4:22:21 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Hrt Financial Lp sold $30,996 worth of Class A Shares (29,802 units at $1.04) and bought $37,985 worth of Class A Shares (41,684 units at $0.91), increasing direct ownership by 35% to 45,636 units (SEC Form 4)

      4 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/11/24 2:48:13 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Smart for Life Inc.

      SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

      11/14/24 6:49:12 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Smart for Life Inc. (Amendment)

      SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

      2/12/24 10:06:22 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Smart for Life Inc. (Amendment)

      SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

      6/6/23 3:54:36 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Leadership Updates

    Live Leadership Updates

    See more
    • Smart for Life Announces Appointment of Jessica Walters as Chief Marketing Officer

      MIAMI, July 09, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced that it has appointed Jessica Walters as the Company's new Chief Marketing Officer. Ms. Walter's appointment as CMO is believed by management to position Smart for Life for long term growth and utilize the Company's IP from its acquisitions to increase sales opportunities across its portfolio. "Our appointment of Jessica Walters as CMO represents a strategic effort to broaden our reach and strengthen our position in the Health and Wellne

      7/9/24 8:30:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • ōku® and Inspired Specialty Products Inc. Appoint Consumer Industry Veteran Ryan F. Zackon as Co-Chair of the Board of Directors

      SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Inspired Specialty Products Inc., creator of the popular ōku® Conscious EnergyTM gummy snacks, proudly announces the appointment of Ryan F. Zackon as co-chair of its Board of Directors. A seasoned leader in the consumer-packaged goods and health and wellness industries, Zackon joins co-chair Kenneth B. Hamlet, former CEO of Holiday Inns Inc. Hotel Group, then the largest hospitality and gaming company in the world, and Patti Larchet, former CEO of Jenny Craig International. "We are excited to welcome Ryan to our team" expressed Carolyn J. Hamlet, founder and CEO. "His proven expertise will be key to propelling ōku®'s strategic growth

      5/7/24 8:58:50 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life Appoints Prominent Industry Executive David Trosin to Company's Advisory Board

      MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a global leader in the Health & Wellness sector marketing and manufacturing nutritional supplements and foods, announced today that it has appointed David Trosin, the Managing Director of Health Sciences Certification at NSF International, to the Company's advisory board. "David Trosin joins Smart for Life with decades of industry experience, and a career providing certification and risk management solutions to international clients, retailers and professional sporting organizations around the world," said Darren Minton, CEO of Smart for Life. "We are excited to have David joi

      4/24/24 8:30:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care